- recruitingPHASE1, PHASE2
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
This study is looking at a new medicine called bleximenib for people with acute leukaemia that has come back or hasn't responded to other treatments. It aims to find the right dose and see how safe and effective it is.
United States · Australia · Belgium - authorisedTherapeutic confirmatory (Phase III)
A phase III Randomized Double-Blinded Placebo-Controlled Study of Use of GnRHa during Chemotherapy for Fertility Protection of Young Women and Teenagers with Cancer - ProFertil
This study looks at whether a drug called GnRHa can protect the ovaries of young women undergoing chemotherapy for certain cancers. It compares women who receive GnRHa with those who receive a dummy treatment to see if it helps preserve their fertility.
Sweden